Medical Plastic Compounds Market Size, Share, and Trends

Medical Plastic Compounds Market Size, Share & Trends Analysis Report By Product (Polyethylene, Polyvinylchloride, Polypropylene, Polyester, Polystyrene, Polycarbonate, Acrylics, Polyurethane, and Others), By Application (Catheters, Disposables, Drug Delivery System, Surgical Instruments, Implants, Medical Bags, and Others) - Global Industry Analysis, Trends, Segment Forecasts, Regional Outlook 2023 - 2032

  • Last Updated : June 2023
  • Report Code : 1155
  • Category : Chemical and Material

The global medical plastic compounds market was valued at USD 69.36 billion in 2022 and is expected to reach USD 125.97 billion by 2032, with a compound annual growth rate (CAGR) of 6.2% during the forecast period 2023 to 2032.

Medical Plastic Compounds Market Size 2023-2032

To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics

Growth Factors

Increasing awareness related to health issues along with subsequent amendments in the regulatory policies for the usage of plastics and its compounds due to environmental concerns is anticipated to impact considerably on the future growth trajectory of the medical plastic compounds market. Rising usage of disposable and sterilized devices coupled with the requirement for medical devices with longer shelf-life are the other major factors that are expected to propel the growth of the market. The utilization of cost-effective and lightweight plastics and the growing importance of prosthetics are estimated to fuel the demand for medical plastic compounds over the analysis period.

Technological advancements, the development of bio-plastics and environment-friendly plastic compounds, and evolved decontamination devices are some of the prime factors predicted to boost the demand for plastic medical devices. Increasing demand for polymers across various applications that include disposables, surgical instruments, catheters, implants, medical bags, and drug delivery systems is expected to prosper the market growth.

Polymers exhibit superior properties that include flexibility, surface control, lightweight, strength, ease of fabrication, rigidity, and the capability to withstand long-term contact with the human body. The aging population particularly in developing countries such as China, Japan, India, and Thailand is touted to elevate the demand for existing as well as new medical technologies.

However, crude oil prices have seen volatility in the past few years. Political instability in significant crude oil-producing countries, that include Venezuela, Iraq, Libya, Nigeria, and Iran has a negative impact on the supply of crude oil that is a prime factor to disturb the equilibrium in supply and demand for the raw material of polymer.

Product Insights

Polyvinylchloride (PVC) dominated the product segment with more than 31% market share in the year 2022. PVC is a versatile, fixed, or rigid material that is widely used as a polymer in single-use pre-sterilized medical devices. Further, rising demand for PVC for the manufacturing of disposables, surgical gloves, feeding, pressure monitoring, and tubing for dialysis is anticipated to flourish the market growth over the forthcoming years.

In terms of revenue, Polypropylene (PP) accounted for a major revenue share and was valued at more than USD 5 billion in the year 2022. The compound is widely used in urinary catheters, heart valve structures, and disposable syringes due to its high bacterial and chemical resistance.

Polycarbonate (PC) is estimated to grow at a steady pace of nearly 6% during the forecast period from 2023 to 2032. PC exhibits superior properties that include optical clarity, better inherent strength, high heat distortion temperature, and dimensional stability.

Application Insights

The disposables emerged as the largest application segment accounting for a value of over USD 11 billion in the year 2022. Further, in terms of demand, the segment accounted for a prominent share because of the rising usage of disposable and sterilized gloves and syringes in the healthcare industry mainly in the countries that include China, Germany, the U.K., and India.

Besides this, the catheter application segment is estimated to witness a steady growth rate of approximately 5.5% during the years 2023 to 2032 due to its increasing application in the healthcare industry such as cardiac electrophysiology, angiography, and angioplasty.

Polymers used for producing medical implants include polyethylene, Polymethyl Methacrylate (PMMA), polyurethane, Polyethylene Terephthalate (PET), polycarbonate, and fluoropolymers. Technological development for example CAD/CAM dentistry is mainly applied in orthodontic applications anticipated to thrive the growth of the implants application segment over the coming years.

Regional Insights

North America is expected to dominate the global medical plastic compound market accounting for a revenue share of over 36% in 2022. The market in the region is mainly driven by the rising incidence of lifestyle-oriented diseases along with government initiatives to improve the facilities and quality of treatments in the healthcare industry.

Surge in medical tourism predominantly in the countries for example the U.K., Germany, and France projected to propel the demand for plastic medical devices. Further, rising home healthcare devices coupled with self-medication in Europe are estimated to prosper the industry growth over the analysis timeframe.

The Asia Pacific healthcare industry is a rapidly growing industry and generates significant demand for new and advanced medical devices that in turn expected to propel the market growth for medical-grade plastic compounds in the region with an estimated rate of 6% between 2023 and 2032.

Key Companies & Market Share Insights

The global medical plastic compounds market is highly attractive owing to the increasing implementation of bio-based plastic compounds for the manufacturing of medical devices and several other applications. The market players significantly believe in expanding their production capacity in order to cater maximum consumer base.

Medical Plastic Compounds Market Companies

  • Nolato AB
  • Freudenberg Medical LLC
  • Rochling Group
  • GW Plastics Inc.
  • MedPlast Inc.
  • Phillips Medisisze Corporation
  • C&J Industries Inc.
  • Tekni-Plex, Inc.
  • Pexco LLC
  • Medical Plastic Devices Inc.

Medical Plastic Compounds Market Scope

Report Highlights Details
Market Size in 2023 USD 73.31 Billion
Market Size by 2032 USD 125.97 Billion
Growth Rate from 2023 to 2032 CAGR of 6.2%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, Application, Region
Companies Mentioned Nolato AB, Freudenberg Medical LLC, Rochling Group, GW Plastics Inc., MedPlast Inc., Phillips Medisisze Corporation, C&J Industries Inc., Tekni-Plex, Inc., Pexco LLC, and Medical Plastic Devices Inc.

 

Segments Covered in the Report

This research study comprises a complete assessment of the market by means of far-reaching qualitative and quantitative perceptions, and predictions regarding the market. This report delivers a classification of the marketplace into impending and niche sectors. Further, this research study calculates the market size and its development drift at global, regional, and country from 2020 to 2032. This report contains a market breakdown and its revenue estimation by classifying it on the basis of product, application, and region:

By Product

  • Polyethylene
  • Polyvinylchloride
  • Polypropylene
  • Polyester
  • Polystyrene
  • Polycarbonate
  • Acrylics
  • Polyurethane
  • Others

By Application

  • Catheters
  • Disposables
  • Drug Delivery System
  • Surgical Instruments
  • Implants
  • Medical Bags
  • Others

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Frequently Asked Questions

The global medical plastic compounds market was valued at USD 69.36 billion in 2022 and expected to reach USD 125.97 billion by 2032.

The global medical plastic compounds market is growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 2023 to 2032.

Polyvinylchloride (PVC) dominated the product segment with more than 31% market share in the year 2022.

The disposables emerged as the largest application segment accounting for a value of over USD 11 billion in the year 2022.

North America expected to dominate the global medical plastic compound market accounting for a revenue share of over 36% in 2022.

The Asia Pacific region hit largest compound annual growth rate (CAGR) in medical plastic compound market.

Some of the key players operating in the market are Nolato AB, Freudenberg Medical LLC, Rochling Group, GW Plastics Inc., MedPlast Inc., Phillips Medisisze Corporation, C&J Industries Inc., Tekni-Plex, Inc., Pexco LLC, and Medical Plastic Devices Inc. among others.

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Medical Plastic Compounds Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Plastic Compounds Market

5.1. Covid-19: Medical Plastic Compounds Industry Impact
5.2. Medical Plastic Compounds Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Medical Plastic Compounds Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Plastic Compounds Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Medical Plastic Compounds Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing Prevalence of Chronic Disease
6.1.1.2. Rising Consumption of Polymers in Healthcare Industry
6.1.2. Market Restraints
6.1.2.1. Volatile Prices of Raw Materials
6.1.3. Market Opportunities
6.1.3.1. Increasing Research Activities to Develop Advanced Medical Grade Plastics
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Medical Plastic Compounds Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Plastic Compounds Market Revenue by Manufacturer
7.1.1.2. Medical Plastic Compounds Market Revenue Market Share by Manufacturer
7.1.1.3. Medical Plastic Compounds Market Production by Manufacturer
7.1.1.4. Medical Plastic Compounds Market Production Market Share by Manufacturer
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Manufacturers Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Medical Plastic Compounds Market, By Product

8.1. Medical Plastic Compounds Market, by Product, 2023-2032
8.1.1. Polyethylene
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.1.2. Market Production and Forecast (2021-2032)
8.1.2. Polyvinylchloride
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.2.2. Market Production and Forecast (2021-2032)
8.1.3. Polypropylene
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.3.2. Market Production and Forecast (2021-2032)
8.1.4. Polyester
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.4.2. Market Production and Forecast (2021-2032)
8.1.5. Polystyrene
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.5.2. Market Production and Forecast (2021-2032)
8.1.6. Polycarbonate
8.1.6.1. Market Revenue and Forecast (2021-2032)
8.1.6.2. Market Production and Forecast (2021-2032)
8.1.7. Acrylics
8.1.7.1. Market Revenue and Forecast (2021-2032)
8.1.7.2. Market Production and Forecast (2021-2032)
8.1.8. Polyurethane
8.1.8.1. Market Revenue and Forecast (2021-2032)
8.1.8.2. Market Production and Forecast (2021-2032)
8.1.9. Others
8.1.9.1. Market Revenue and Forecast (2021-2032)
8.1.9.2. Market Production and Forecast (2021-2032)

Chapter 9. Global Medical Plastic Compounds Market, By Application

9.1. Medical Plastic Compounds Market, by Application, 2023-2032
9.1.1. Catheters
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.1.2. Market Consumption and Forecast (2021-2032)
9.1.2. Disposables
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.2.2. Market Consumption and Forecast (2021-2032)
9.1.3. Drug Delivery System
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.3.2. Market Consumption and Forecast (2021-2032)
9.1.4. Surgical Instruments
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.4.2. Market Consumption and Forecast (2021-2032)
9.1.5. Implants
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.5.2. Market Consumption and Forecast (2021-2032)
9.1.6. Medical Bags
9.1.6.1. Market Revenue and Forecast (2021-2032)
9.1.6.2. Market Consumption and Forecast (2021-2032)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2021-2032)
9.1.7.2. Market Consumption and Forecast (2021-2032)

Chapter 10. Global Medical Plastic Compounds Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Production Forecast by Product (2021-2032)
10.1.2. Market Revenue and Consumption Forecast by Application (2021-2032)
10.1.3. U.S
10.1.3.1. Market Revenue and Production Forecast (2021-2032)
10.1.3.2. Market Revenue and Consumption Forecast (2021-2032)
10.1.4. Canada
10.1.4.1. Market Revenue and Production Forecast (2021-2032)
10.1.4.2. Market Revenue and Consumption Forecast (2021-2032)
10.2. Europe
10.2.1. Market Revenue and Production Forecast by Product (2021-2032)
10.2.2. Market Revenue and Consumption Forecast by Application (2021-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Production Forecast (2021-2032)
10.2.3.2. Market Revenue and Consumption Forecast (2021-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Production Forecast (2021-2032)
10.2.4.2. Market Revenue and Consumption Forecast (2021-2032)
10.2.5. France
10.2.5.1. Market Revenue and Production Forecast (2021-2032)
10.2.5.2. Market Revenue and Consumption Forecast (2021-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue and Production Forecast (2021-2032)
10.2.6.2. Market Revenue and Consumption Forecast (2021-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue and Production Forecast by Product (2021-2032)
10.3.2. Market Revenue and Consumption Forecast by Application (2021-2032)
10.3.3. China
10.3.3.1. Market Revenue and Production Forecast (2021-2032)
10.3.3.2. Market Revenue and Consumption Forecast (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue and Production Forecast (2021-2032)
10.3.4.2. Market Revenue and Consumption Forecast (2021-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Production Forecast (2021-2032)
10.3.5.2. Market Revenue and Consumption Forecast (2021-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Production Forecast (2021-2032)
10.3.6.2. Market Revenue and Consumption Forecast (2021-2032)
10.4. LATAM
10.4.1. Market Revenue and Production Forecast by Product (2021-2032)
10.4.2. Market Revenue and Consumption Forecast by Application (2021-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue and Production Forecast (2021-2032)
10.4.3.2. Market Revenue and Consumption Forecast (2021-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue and Production Forecast (2021-2032)
10.4.4.2. Market Revenue and Consumption Forecast (2021-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue and Production Forecast by Product (2021-2032)
10.5.2. Market Revenue and Consumption Forecast by Application (2021-2032)
10.5.3. GCC
10.5.3.1. Market Revenue and Production Forecast (2021-2032)
10.5.3.2. Market Revenue and Consumption Forecast (2021-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue and Production Forecast (2021-2032)
10.5.4.2. Market Revenue and Consumption Forecast (2021-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue and Production Forecast (2021-2032)
10.5.5.2. Market Revenue and Consumption Forecast (2021-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue and Production Forecast (2021-2032)
10.5.6.2. Market Revenue and Consumption Forecast (2021-2032)

Chapter 11. Company Profiles

11.1. Nolato AB
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Production Capacity, Price, and Gross Margin
11.1.4. Recent Developments and Strategies
11.2. Freudenberg Medical LLC
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Production Capacity, Price, and Gross Margin
11.2.4. Recent Developments and Strategies
11.3. Rochling Group
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Production Capacity, Price, and Gross Margin
11.3.4. Recent Developments and Strategies
11.4. GW Plastics Inc.
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Production Capacity, Price, and Gross Margin
11.4.4. Recent Developments and Strategies
11.5. MedPlast Inc.
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Production Capacity, Price, and Gross Margin
11.5.4. Recent Developments and Strategies
11.6. Phillips Medisisze Corporation
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Production Capacity, Price, and Gross Margin
11.6.4. Recent Developments and Strategies
11.7. C&J Industries Inc.
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Production Capacity, Price, and Gross Margin
11.7.4. Recent Developments and Strategies
11.8. Tekni-Plex, Inc.
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Production Capacity, Price, and Gross Margin
11.8.4. Recent Developments and Strategies
11.9. Pexco LLC
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Production Capacity, Price, and Gross Margin
11.9.4. Recent Developments and Strategies
11.10. Medical Plastic Devices Inc.
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Production Capacity, Price, and Gross Margin
11.10.4. Recent Developments and Strategies

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client